Cape Investment Advisory, Inc. Ligand Pharmaceuticals Inc Transaction History
Cape Investment Advisory, Inc.
- $247 Billion
- Q3 2024
A detailed history of Cape Investment Advisory, Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Cape Investment Advisory, Inc. holds 63 shares of LGND stock, worth $7,197. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63
Previous 63
-0.0%
Holding current value
$7,197
Previous $5.31 Million
18.8%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding LGND
# of Institutions
256Shares Held
18.1MCall Options Held
26.8KPut Options Held
9.3K-
Black Rock Inc. New York, NY2.87MShares$328 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.97MShares$225 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$115 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3887KShares$101 Million0.1% of portfolio
-
State Street Corp Boston, MA707KShares$80.8 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.93B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...